{"@id":"https://bioecon.ru/technology/biotech-ip-valuation/","@type":"Technology","cluster":"regulatory-legal","formats":{"html":"https://bioecon.ru/technology/biotech-ip-valuation/","json":"https://bioecon.ru/api/v1/technology/biotech-ip-valuation/index.json"},"id":"biotech-ip-valuation","industries":["services"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/codexis/","https://bioecon.ru/companies/bbca-group/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/granbio/","https://bioecon.ru/companies/life3-biotech/","https://bioecon.ru/companies/huazhi-rice-gene-technology/","https://bioecon.ru/companies/united-therapeutics/","https://bioecon.ru/companies/roche-holding/"]},"maturity":null,"name":"Оценка интеллектуальной собственности в биотехе","regions":["us","eu","in","cn"],"risk":"low","section":"technology","sector":"services-governance-capital","sources":[{"date":"2026-07-09","entity":"ocean-tomo","kind":"vendor","urls":[]},{"date":"2026-08-08","entity":"consor-ip-consulting","kind":"vendor","urls":[]},{"date":"2026-08-04","entity":"cra-ip-valuation","kind":"vendor","urls":[]},{"date":"2026-08-11","entity":"everedge-global","kind":"vendor","urls":[]},{"date":"2026-08-05","entity":"aon-ip-solutions","kind":"vendor","urls":[]},{"date":"2026-07-16","entity":"greyb","kind":"vendor","urls":[]},{"date":"2026-08-12","entity":"ktmine","kind":"vendor","urls":[]},{"date":"2026-08-16","entity":"zhongjinhao-asset-appraisal","kind":"vendor","urls":[]},{"date":"2026-05-26","entity":"inngot","kind":"vendor","urls":[]},{"date":"2026-08-16","entity":"china-sciences-exchange-ip","kind":"vendor","urls":[]}],"stages":[{"n":1,"title":"Идентификация патентного портфеля"},{"n":2,"title":"Анализ известного уровня техники и формулы"},{"n":3,"title":"Выбор методологии оценки"},{"n":4,"title":"Бенчмаркинг ставок роялти"},{"n":5,"title":"Определение денежной стоимости"},{"n":6,"title":"Доставка отчёта об оценке"}],"summary":"Консалтинговые фирмы и платформы данных, оценивающие патентные портфели биотехнологических и фармацевтических компаний для лицензионных переговоров, сделок M\u0026A, судебных споров и привлечения капитала — переводящие патентный портфель, охватывающий терапевтические средства, диагностику или платформенные технологии, в защищаемую денежную оценку.","url":"/technology/biotech-ip-valuation/","verified":"2026-08-16"}